Image-guided intensity-modulated radiotherapy with reduced margins in patients with prostate cancer: Results of the RCMIGI randomized phase II trial
Year: 2025
Type: article
Language: en
Topic: Prostate Cancer Diagnosis and Treatment
Authors and affiliations:
raw_author_name: Olivier Riou
raw_affiliation_strings: Department of Radiation Oncology, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France; Inserm U1194, Montpellier Cancer Research Institute (IRCM), University of Montpellier, Montpellier, France; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier, France. Electronic address: Olivier.Riou@icm.unicancer.fr
raw_author_name: Pascal Fenoglietto
raw_affiliation_strings: Department of Radiation Oncology, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier, France
raw_author_name: Marta Jarlier
raw_affiliation_strings: Biometrics Unit, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France
raw_author_name: Jessica Prunaretty
raw_affiliation_strings: Department of Radiation Oncology, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier, France
raw_author_name: Norbert Aillères
raw_affiliation_strings: Department of Radiation Oncology, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier, France
raw_author_name: Grégoire Poinas
raw_affiliation_strings: Department of Supportive Care, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France; Department of Urology, Beau Soleil Clinic, Montpellier, France
raw_author_name: Pierre Debuire
raw_affiliation_strings: Department of Radiation Oncology, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier, France
raw_author_name: Sophie Gourgou
raw_affiliation_strings: Biometrics Unit, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France
raw_author_name: Laetitia Meignant
raw_affiliation_strings: Department of Clinical Research and Innovation, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France
Clinical Research and Innovation Department, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France
raw_author_name: Bruno Segui
raw_affiliation_strings: Department of Urology, Beau Soleil Clinic, Montpellier, France; Department of Urology, Saint Jean Sud de France Clinic, Montpellier, France
raw_author_name: Carmen Llacer Moscardo
raw_affiliation_strings: Department of Radiation Oncology, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier, France
raw_author_name: Marie Charissoux
raw_affiliation_strings: Department of Radiation Oncology, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier, France
raw_author_name: David Azria
raw_affiliation_strings: Department of Radiation Oncology, Montpellier Cancer Institute (ICM), University of Montpellier, Montpellier, France; Inserm U1194, Montpellier Cancer Research Institute (IRCM), University of Montpellier, Montpellier, France; University Federation of Radiation Oncology of Mediterranean Occitanie, Montpellier, France